WE ARE COMMITED

WE ARE COMMITTED TO ADVANCING THE GLOBAL HIV RESPONSE

If we want to end the epidemic, we need to commit to a few things first; ensuring equitable access to medicines for all people living with HIV, challenge health inequities across the globe, and continue to fight HIV related stigma.

HIV is not a solved problem and we won't stop until it is. That's a promise.

IMPROVING ACCESS TO OUR MEDICINES

SUPPORTING HEALTH EQUITY, EVERYWHERE

FIGHTING HIV STIGMA, ALWAYS.

COMMITMENT TO TESTING

WHAT WILL IT TAKE TO END HIV? IT TAKES A VILLAGE

Read more stories from ViiV here

In this article, Deborah Waterhouse, our CEO, reflects on her time at AIDS 2024. She discusses the theme of ‘Putting People First’ and the need to continue to work together to end HIV.

In collaboration with Politico, we explore how Governments, civil society and industry share views on the EU mandate we need to achieve the 2030 UNAIDS goals in Europe and beyond.

In this article, Mercy Shibemba shares her hopes and aspirations for the future. She reflects on how living with HIV shaped her childhood and how her concept of healthy living may shift as she
gets older.

NP-GBL-HVX-COCO-240036 August 2024

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.